FILTER

FILTERED INTERVIEW RESULTS

United States
Pharma & Life Sciences

Kendalle O’Connell

CEO AND PRESIDENT, MASSBIO
"In 2022, Massachusetts received 25% of all biopharma VC funding in the US. We are seeing new clusters emerge outside the traditional hubs of Kendall Square and Boston."
United States
Pharma & Life Sciences

Arda Ural

AMERICAS INDUSTRY MARKET LEADER, HEALTH SCIENCES & WELLNESS, EY USA
"We are going to help the industry digitalize, prepare for the innovation deficit due to expiring patents and improve strategies that lead to better M&A opportunities."
Mining
United States

Eric J. Mears

VICE PRESIDENT, HALEY & ALDRICH
"Arizona currently uses as much water now as it did in the mid 1950’s. Conservation, water banking, and forward-looking water laws have played a tremendous role in this."
Mining
United States

Darryl Sockwell & Michael Judd

WEST COAST DIVISION DISTRICT MANAGER (DS) & WEST COAST DIVISION BUSINESS DEVELOPMENT MANAGER (MJ), MMR CONSTRUCTORS
“We have tremendous growth opportunities, particularly in the western region where many of the larger mines are located. The schedule and demand in the mining sector is aggressive and I don’t see it slowing down anytime soon.”
United States
Pharma & Life Sciences

David Schaffer

EXECUTIVE DIRECTOR, QB3
"The Bay Area offers a confluence of universities, investors and companies, and we are interested in strengthening bridges between these institutions to streamline the process of technology translation."
United States
Pharma & Life Sciences

Mark A. Goldberg

CEO, ALLUCENT
"Given that a significant amount of intellectual property and cutting-edge science resides within smaller companies, we created a purpose-built firm to help smaller players develop their products and bring them to market."
United States
Pharma & Life Sciences

Gil Roth

PRESIDENT, PBOA
"The Ukraine crisis highlighted how Europe needs to look at its energy supply and how it will make sure they have secure supply chains. Part of that has involved the US more closely. Geopolitics will have a more significant impact going forward."
United States
Pharma & Life Sciences

Terry Myerson

CEO, TRUVETA
"Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19."
United States
Pharma & Life Sciences

Liping Liu

FOUNDER & CEO, HIGHTIDE THERAPEUTICS
"As more robust drug candidates are emerging, I am willing to bet that we will have the first NASH drug approved in 2023."
Mining
United States

Scott Bedell

PRESIDENT, CALTROL INC.
"Companies are asking for more return from past automation investments and additional, relevant data for decision-making."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mexico Chemicals 2025 CW Release

Mexico's chemical industry faces challenges in securing a reliable feedstock supply and maintaining global competitiveness. A shift towards sustainable energy and local production could provide long-term growth opportunities, and some sectors are booming, including Mexico's dynamic chemical distribution market.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL